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Background: Antibody opsonization of Plasmodium falciparum-infected erythrocytes (IE) plays a crucial role in
anti-malarial immunity by promoting clearance of blood-stage infection by monocytes and macrophages. The
effects of phagocytosis of opsonized IE on macrophage pro-inflammatory cytokine responses are poorly
understood.
Methods: Phagocytic clearance, cytokine response and intracellular signalling were measured using IFN-γ-primed
human monocyte-derived macrophages (MDM) incubated with opsonized and unopsonized trophozoite-stage CS2
IE, a chondroitin sulphate-binding malaria strain. Cytokine secretion was measured by bead array or ELISA, mRNA
using quantitative PCR, and activation of NF-κB by Western blot and electrophoretic mobility shift assay. Data were
analysed using the Mann–Whitney U test or the Wilcoxon signed rank test as appropriate.
Results: Unopsonized CS2 IE were not phagocytosed whereas IE opsonized with pooled patient immune serum
(PPS) were (Phagocytic index (PI)=18.4, [SE 0.38] n=3). Unopsonized and opsonized IE induced expression of TNF,
IL-1β and IL-6 mRNA by MDM and activated NF-κB to a similar extent. Unopsonized IE induced secretion of IL-6
(median= 622 pg/ml [IQR=1,250-240], n=9) but no IL-1β or TNF, whereas PPS-opsonized IE induced secretion
of IL-1β (18.6 pg/mL [34.2-14.4]) and TNF (113 pg/ml [421–17.0]) and increased IL-6 secretion (2,195 pg/ml
[4,658-1,095]). Opsonized, but not unopsonized, CS2 IE activated caspase-1 cleavage and enzymatic activity in
MDM showing that Fc receptor-mediated phagocytosis activates the inflammasome. MDM attached to IgG-coated
surfaces however secreted IL-1β in response to unopsonized IE, suggesting that internalization of IE is not
absolutely required to activate the inflammasome and stimulate IL-1β secretion.
Conclusions: It is concluded that IL-6 secretion from MDM in response to CS2 IE does not require phagocytosis,
whereas secretion of TNF and IL-1β is dependent on Fcγ receptor-mediated phagocytosis; for IL-1β, this occurs by
activation of the inflammasome. The data presented in this paper show that generating antibody responses to
blood-stage malaria parasites is potentially beneficial both in reducing parasitaemia via Fcγ receptor-dependent
macrophage phagocytosis and in generating a robust pro-inflammatory response.
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There are an estimated 243 million clinical cases of mal-
aria each year, resulting in almost 800,000 deaths (World
Health Organization, World Malaria Report 2010). The
burden of disease falls mainly on children under five years
old and women in their first and second pregnancies (ibid,
[1]). The majority of deaths in children, and morbidity
associated with infection in pregnancy, are due to infec-
tion by Plasmodium falciparum. The production of anti-
bodies to the blood stages of malaria parasites represents
an important component of anti-malarial immunity. This
is most clearly shown by the ability of passively transferred
gamma globulin to clear blood-stage infection and allevi-
ate clinical illness [2,3]. The mechanism of protection
afforded by gamma globulins purified from hyperimmune
donors is assumed to have occurred by transfer of malaria
specific antibodies, however it cannot be ruled out that al-
leviation of disease symptoms may also be contributed by
the immunomodulatory properties of intravenously admi-
nistered gamma globulins [4]. The role of antibodies in
protection from malaria is also shown by the protection
afforded to newborn infants from maternal antibodies
(although see [5]) and is suggested by an association of
the titre of antibodies to malaria antigens with decreased
risk of disease [6]. Protective antibodies are directed
against merozoite proteins and variant surface antigens
expressed on infected erythrocytes (IE) [7,8].
The mechanism(s) by which antibodies confer protec-
tion needs to be defined in order to inform vaccine devel-
opment. Mechanisms that have been proposed include
inhibition of parasite growth [9-11], neutralization of sur-
face proteins involved in merozoite entry into red blood
cells [12-14], inhibition of IE sequestration [15], and pro-
motion of parasite killing [16] or phagocytosis via Fcγ
receptor-dependent mechanisms [16,17](reviewed in [18]).
Antibody responses associated with protection in both
children and pregnant women have been shown to be
mainly comprised of cytophilic IgG antibodies of the sub-
classes IgG1 and IgG3 [19-26], which suggests a role for
Fcγ receptors in protection. The role of Fcγ receptors in
malaria immunity is supported by observations of a link
between Fcγ receptor polymorphisms and outcomes of in-
fection [27-30].
Erythrocytes infected with trophozoite-stage parasites
are cleared in the spleen, liver and placenta by mono-
cytes and monocyte-derived tissue macrophages
(MDM).Antibodies to trophozoite-stage IE surface pro-
teins opsonize IE and promote their removal by
erythrophagocytosis. Engagement of Fcγ receptors on
myeloid cells increases the efficiency of ingestion by
phagocytosis and stimulates cytokine production, but
may also alter the programme of inflammatory gene ex-
pression by macrophages in comparison to that induced
by stimulation of innate immune receptors [31,32]. Pro-inflammatory cytokines are thought to have a role in
limiting malaria parasitaemia in part via activation of
the innate immune mechanisms of monocytes and
macrophages. They may also play a role in immuno-
pathogenesis, as originally postulated by Clark and co-
workers from their studies on mouse models of malaria
[33]. This dual potential is illustrated by mouse models
of malaria infection in which the effect of loss of pro-
inflammatory cytokine production in IRAK4−/− mice,
whose monocytes have defective cytokine production
due to loss of signalling from multiple toll-like recep-
tors, has either a beneficial or deleterious effect on out-
comes depending upon the susceptibility of the mouse
strain [34]. It is, therefore, crucially important to under-
stand how opsonization by immune serum affects pro-
inflammatory cytokine production in response to
malaria antigens.
As part of studies to investigate how opsonization of
IE affects cytokine production by MDM, and how HIV
infection of MDM may alter these responses [35], the in-
fluence of opsonization with immune serum on the pro-
duction of the pro-inflammatory cytokines IL-1β, TNF
and IL-6, by human MDM exposed to trophozoite-stage
P. falciparum IE was investigated. To avoid complica-
tions of non-opsonic phagocytosis via CD36, the CS2
parasite strain [36], a model for chondroitin sulphate A
(CSA) binding maternal malaria parasites which does
not bind to CD36, was studied. It is shown that mRNA
encoding IL-1β, TNF and IL-6 is induced by unopso-
nized IE in the absence of phagocytosis, and that
opsonization with IgG enhances phagocytosis and IL-6
protein secretion, and enhances IL-1β secretion via ac-
tivation of the inflammasome. These data show that
pro-inflammatory cytokine gene expression is acti-
vated via surface-expressed innate immune receptors
and requires additional signals, which may be derived
from Fcγ receptor signalling pathways or internal pat-
tern recognition receptors, to promote robust pro-
inflammatory cytokine secretion.
Methods
Isolation of monocytes and culture of monocyte-derived
tissue macrophages
Human peripheral blood mononuclear cells (PBMC) were
obtained from Buffy Coats separated from volunteer blood
donations (Australian Red Cross Blood Service, South-
bank, Victoria, Australia) using Ficoll-Paque™ density gra-
dient centrifugation. Monocytes were isolated from PBMC
by countercurrent elutriation using a Beckman J-6M/E
centrifuge equipped with a JE 5.0 rotor and tested for
purity as described previously [37]. MDM were pre-
pared by culturing freshly isolated monocytes adhered
to plastic in Iscove’s modified Dulbecco’s medium
(Invitrogen) containing 10% heat-inactivated human
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supplemented with 2 mM glutamine, 100 U/mL peni-
cillin G and 100 μg/mL streptomycin sulphate (IH10
medium). MDM were cultured as described [35], and
where indicated they were activated for 48 hr with 100
ng/ml human IFN-γ (R&D Systems).
Preparation and opsonization of CS2 IE
The CSA binding P. falciparum strain CS2 [36] was
maintained in unexpired human group O+ erythrocytes
(Australian Red Cross Blood Service) in RPMI-HEPES
supplemented with 0.5% Albumax II (GIBCO) and 25
mM NaHCO3 and tested for CSA adhesion and Myco-
plasma contamination as described [17,35]. Mature
trophozoite-stage IE were purified from discontinuous
Percoll gradients as described [17,35]. IE collected from
the 60% layer (92-95% purity) were washed three times
and re-suspended in PBS at a density of 1x108 per ml
then opsonized for 30 min at room temperature with 9%
pooled patient immune serum (PPS) from Malawian
HIV-uninfected pregnant women with malaria, which
demonstrated high levels of antibody to CS2 IE [17], or
left unopsonized. In some experiments, IE were opso-
nised as above with 10% non-immune human serum
prepared from pooled serum from healthy Australian
donors (provided by the Australian Red Cross Blood
Service). IE were washed and re-suspended in PBS at
1x108/ml and used immediately.
Measurement of phagocytosis
IE were added to MDM cultured in 96-well plates at a
target to cell ratio of 20:1 unless otherwise indicated,
then incubated for 1 hr. The extent of phagocytosis was
determined by measuring internalized haemoglobin
using a colorimetric assay as described [17] [35,38]. The
haemoglobin content was converted to equivalents of
erythrocytes ingested by reference to a standard curve of
known amounts of IE from the same preparation, and
phagocytosis expressed as a phagocytic index represent-
ing erythrocytes ingested per 100 MDM.
Measurement of cytokine gene expression and protein
secretion
MDM were cultured in 96-well plates and exposed in
triplicate to IE under varying conditions of opsonization
for 24 hr. Media from triplicate wells were collected,
pooled, then analysed for cytokines using a cytokine
bead array (BD Biosciences, Human Inflammatory
Cytokine Kit). In some experiments, culture medium
was analysed for IL-6 secretion using an ELISA assay
(Mabtech AB). To measure mRNA expression, MDM
were cultured in 24-well plates and exposed to IE for
various times then lysed using lysis buffer A (0.1 M Tris
HCl, pH 7.5 containing 1% lithium dodecyl sulphate, 0.5M LiCl, 10 mM EDTA, 5 mM DTT) to extract total cel-
lular RNA. Cellular mRNA was isolated from extracts
using oligo(dT) magnetic beads (GenoPrepTM, GenoVi-
sion), and cDNA was prepared using a Transcriptor First
Strand cDNA Synthesis Kit (Roche) followed by amplifi-
cation of cytokine cDNAs by quantitative real-time PCR
in BrilliantW II SYBRW Green qPCR Master Mix (Strata-
gene) using primer pairs for TNF, IL-1β and IL-6 and
amplifications as previously described [35,39].
Western blot detecting nuclear localization of NF-κB
subunits
MDM (1x106 per 6 cm dish) were primed with IFN-γ for
48 hr and treated with media alone, IE or IE opsonized
with PPS for 24 hr, or with 1 ng/ml LPS for 2 hr followed
by preparation of nuclear and cytoplasmic extracts using
NE-PERW Nuclear and Cytoplasmic Extraction Reagents
and Halt™ Protease and Phosphatase Inhibitor Cocktail,
EDTA-free, according to the manufacturer’s protocol
(Pierce Biotechnology). Protein concentration was deter-
mined using the Lowry method (BioRad) and 100 μg pro-
tein was boiled in protein loading buffer and separated by
SDS-PAGE for immunoblot analysis. Protein was trans-
ferred onto nitrocellulose, and probed with antibodies as
follows: rabbit anti-NF-κB p105/p50 (#3035, 1:1000) (Cell
Signalling Technologies), rabbit anti-NF-κB p65 (C20,
1:1000) (Santa Cruz Biotechnology), rabbit anti-TATA
binding protein TBP (ab63766, 1:1000) (AbCam) and
mouse anti-GAPDH (6C5, 1:2500) (Santa Cruz Biotech-
nology). Primary antibody incubations were performed
overnight at 4°C. Secondary antibodies used were HRP-
conjugated donkey anti-rabbit and sheep anti-mouse IgG
(GE Healthcare, Amersham) and detection was performed
with enhanced chemiluminescence reagent (GE Health-
care, Amersham).
Electrophoretic mobility shift assay (EMSA)
Single-stranded DNA oligonucleotides were generated
containing NF-κB consensus sequence: Forward: 5’
AGTTGAGGGGACTTTCCCAGGC 3’ and Reverse: 5’
GCCTGGGAAAGTCCCCTCAACT 3’. In addition, NF-
κB mutant oligonucleotides were synthesised: Forward:
5’ AGTTGAGGCGACTTTCCCAGGC 3’ and Reverse:
5’ GCCTGGGAAAGTCGCCTCAACT 3’ (GeneWorks).
NF-κB consensus sequence oligonucleotides were la-
belled using the Biotin 3’-End DNA Labelling Kit (Pierce
Biotechnology) and annealed. Unlabelled and mutant
NF-κB oligonucleotides were annealed for use in compe-
tition experiments. NF-κB binding activity was deter-
mined using the LightShift Chemiluminescent EMSA
Kit (Pierce Biotechnology). Nuclear protein extract (5 μg
protein) was incubated for 40 min in binding buffer con-
taining 200 ng poly dI:dC, 1% NP-40 and 50% glycerol
with labelled probe. For competition assays, 100-fold
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probe was added 20 min prior to labelled probe as
described [40]. For supershift assays, 2 μg of rabbit poly-
clonal antibody against NF-κB p65 (H-286) or p50 (H-
119, Santa Cruz Biotechnology) or control antibody were
incubated with nuclear extracts 20 min prior to adding la-
belled probe [40]. Complexes were resolved using 4-20%
Tris-Borate EDTA (TBE) native polyacrylamide gels
(Lonza) in 0.5x TBE running buffer at 4°C and transferred
to BiodyneW B nylon membrane (Pierce Biotechnology).
Detection was achieved using the Chemiluminescent
Nucleic Acid Detection Module (Pierce Biotechnology).Fcγ receptor cross-linking experiments
Wells of 96-well plates were coated with 1 mg/ml
human IgG (kind gift of Prof M Hogarth) overnight at
4°C then washed twice with calcium and magnesium free
PBS. MDM grown for 7 days under non-adherent condi-
tions in Teflon jars (Minnetonka), and primed with IFN-
γ for 48 h, were added at 50,000 per well and adhered
for 30 min. Cells were washed twice with PBS then
exposed to 0.5-2.0 x106 unopsonized CS2 IE for 24 hr
(10–40:1 ratio of target to MDM). Culture medium was
collected, and triplicate wells were pooled for measure-
ment of cytokine secretion as described. Parallel wells
were also seeded with 50,000 MDM in triplicate to
measure phagocytosis of IE and opsonized IE.
Analysis of caspase 1 activity
IFN-γ primed MDM cultured in 6 cm dishes were
exposed for 4 hr to 6x107 CS2 IE opsonized with sub-
agglutinating concentrations (1:600) of rabbit anti-
human erythrocyte antibody (MP Biomedicals) or to an
equal number of unopsonized IE. Unbound IE were
removed by washing once with ice-cold PBS, then bound
but uningested IE were removed by lysis for 3 min with
0.2% NaCl followed by washing in ice-cold PBS. MDM
were lyzed with 100 μL RIPA buffer (25 mM Tris–HCl
(pH 7.5), 0.14 M NaCl, 1 mM EDTA, 0.1% SDS) supple-
mented with protease inhibitors (Roche, Complete
protease inhibitor cocktail) and phosphatase inhibitors
(50 mM NaF, 1 mM sodium orthovanadate, 40 mM
β-glycerophosphate) for 15 min at 4°C. Lysates were
clarified by centrifugation (20,000 xg,/10 min, 4°C) and
50 μg of protein was analysed by immunoblotting for
caspase-1 activation (anti caspase-1 p10, sc-515, 1:400,
Santa Cruz Biotechnology) using 15% acrylamide gels.
Gels were re-probed with mouse anti-GAPDH (6C5,
1:2500, Santa Cruz Biotechnology) as a loading control.
To measure the effect of caspase inhibition on cyto-
kine secretion, MDM cultured in 96-well plates were
pre-incubated for 2 hr with 10 μM benzyloxycarbonyl
Val-Ala-Asp (zVAD)–FMK before stimulation withopsonized or unopsonized CS2 IE, and cytokine secre-
tion was measured as described after 24 hr.
To measure caspase enzymatic activity, IFN-γ-primed
MDM cultured in 6 cm dishes were exposed to opsonized
or unopsonized CS2 IE at a ratio of 20 IE per cell for 0–4
hr. Extracts were prepared and assayed using a fluorogenic
substrate according to manufacturer’s protocol (Caspase-1
fluorometric assay, R&D systems, BF12100).
Statistical analysis
Statistical significance between groups was calculated
using the Mann–Whitney non-parametric U test or, for
paired comparisons, the Wilcoxon signed rank test. All
statistical analyses were carried out using Prism 5.0 soft-
ware (GraphPad Software). Significance was assumed
when probability value was <0.05 in all cases.
Ethics
Sera used to produce the positive pool were collected as
part of studies approved by the College of Medicine
Research Ethics Committee, Blantyre, Malawi and the
Melbourne Health Human Research Ethics Committee,
Melbourne.
Results
Phagocytosis of trophozoite-stage CS2 IE
To characterize phagocytic uptake of CS2 IE by MDM,
seven-day adherent MDM cultures were exposed to un-
infected erythrocytes (E) and to purified IE opsonized
using various conditions and at varying target-to-effector
ratios, and phagocytic indices were measured. Freshly
isolated human erythrocytes were not ingested by MDM
but were efficiently ingested when opsonized with rabbit
anti-human erythrocyte antibody, which served as the
positive control. IE were not ingested by MDM unless
opsonized with PPS. Phagocytosis of IgG-opsonized tar-
gets reached a plateau at a target to macrophage ratio of
20:1 (Figure 1A) and this ratio was used in all subse-
quent experiments unless otherwise indicated. Priming
of MDM with IFN-γ increased phagocytosis of antibody-
opsonized CS2 IE without inducing phagocytosis of
unopsonized CS2 IE (Figure 1B). Subsequent experi-
ments were conducted using MDM primed with 100 ng/
ml IFN-γ for 48 hr. In separate experiments it was
shown that IE opsonised with non-immune serum were
not phagocytosed at a greater rate compared to unopso-
nised IE (relative phagocytic index non-immune serum:
unopsonised = 0.94, sd = 0.16, n=3).
IL-1β, TNF and IL-6 mRNA are induced by unopsonized
and opsonized CS2 IE
To determine whether ingestion of CS2 IE via phagocyt-
osis was required to elicit a pro-inflammatory response,
MDM were exposed to unopsonized and opsonized IE
A B
Figure 1 Opsonized but not unopsonized CS2 IE are ingested by IFN-γ primed and unprimed MDM. (A) MDM were cultured for seven
days in 96-well plates at 50,000 per well then exposed to human erythrocytes (●), human erythrocytes opsonized with rabbit anti-erythrocyte
antibody (○), purified CS2 IE (▲) or purified CS2 IE opsonized with immune serum (■) at the indicated target to cell ratios. After 2 hr, the
number of ingested erythrocytes was determined using phagocytosis assay as described in Methods and expressed as a phagocytic index
(ingested erythrocytes per 100 MDM). Values represent mean ± SEM of triplicate determinations from a single donor monocyte preparation.
(B) MDM were cultured as in (A) but incubated with (+) or without (−) 100 ng/ml IFN-γ between day 5 and day 7. MDM were then exposed to
targets (20:1 target to cell ratio) for 1 hr and phagocytic indices determined. E: human erythrocytes, IE: CS2 trophozoites, IE-PPS: CS2 trophozoites
opsonized with PPS, IE-IgG: CS2 trophozoites opsonized with rabbit anti-human erythrocyte IgG. Data represent mean ± SEM of quadruplicate
determinations from a single donor monocyte preparation. Experiment is representative of two independent experiments.
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IL-1β was measured. All mRNA species were induced
after 30 min, and reached a peak at 4 hr (Figure 2).
Significantly, the levels and kinetics of induction of
mRNA for these cytokines were similar when MDM
were exposed to unopsonized or opsonized IE, suggest-
ing that ingestion was not required for a robust
transcriptional response. Pro-inflammatory cytokine
transcription in response to innate immune stimuli is
regulated by NF-κB [41]. The ability of IE or opsonized
IE to activate the NF-κB pathway was therefore deter-
mined. Activation was initially assessed by p50 (NF-κB1)
and p65 (RelA) subunit translocation to the nucleus. Nu-
clear protein fractionation was validated using antibodies
against the nuclear protein TATA binding protein TBP
and the cytoplasmic protein GAPDH. Resting MDM
contained low levels of p50 or p65 immunoreactivity in
the nucleus (Figure 3A). Exposure to unopsonized CS2
IE resulted in accumulation of both p65 and p50 in nu-
clei, which was not enhanced when MDM were exposed
to opsonized IE. The effect of IE or opsonized IE on NF-
κB pathway activation was also assessed by electrophor-
etic mobility shift assay (EMSA) using an NF-κB consen-
sus biotin-labelled oligonucleotide. Using the EMSA
technique very low levels of specific NF-κB complexes
were detected in nuclei of resting MDM, but these com-
plexes were readily detected when MDM were exposed
to CS2 IE and the levels of these complexes were not
further enhanced upon exposure to opsonized CS2 IE
(Figure 3B). Binding of the biotin-labelled NF-κB probeto nuclear extracts prepared from MDM stimulated with
IE and opsonized IE was diminished following addition
of 100-fold molar excess of unlabelled NF-κB probe.
This competition experiment indicated specificity of the
protein complex for the NF-κB consensus oligonucleo-
tide. The mutant NF-κB probe did not compete with the
biotin-labelled NF-κB probe indicating specificity. Fur-
thermore, addition of anti-p50 and anti-p65 antibodies
significantly diminished the NF-κB complex confirming
the presence of these proteins in the oligonucleotide
binding complex. Taken together, these data suggest that
recognition of unopsonized trophozoite-stage CS2 IE by
MDM is sufficient to stimulate NF-κB signalling and
pro-inflammatory cytokine mRNA expression in the ab-
sence of phagocytosis.
Pro-inflammatory cytokine secretion in response to IE
To determine the effect of IFNγ priming and antibody
opsonization on TNF, IL-1β and IL-6 secretion, MDM
were incubated with human erythrocytes, IE or PPS-
opsonized IE for 24 hr, and the concentrations of cyto-
kines in culture medium were quantified. Unprimed
MDM exposed to human erythrocytes as a negative
control secreted no IL-1β and this was not increased
following incubation with CS2 IE (median [IQR] = 3.98
[2.92-8.47] cf 5.49 [2.82-8.56] pg/ml, background values
~5 pg/ml in this assay, Figure 4A). Similar results were
obtained using MDM primed with IFN-γ with the
same targets (median [IQR] = 5.17 [2.80-9.61] cf 5.80
[3.81-9.23] pg/ml, p = 0.94, Figure 4B). Similarly,
Figure 2 Unopsonized and opsonized CS2 IE induce
comparable pro-inflammatory cytokine mRNA expression. MDM
cultured in 24-well plates were primed with IFN-γ for 48 hr, and
then exposed to purified CS2 IE opsonized with PPS(●) or without
opsonization (○) at an IE to MDM ratio of 20:1. RNA extracts were
prepared after the indicated times and analysed by qPCR for
cytokine and GAPDH mRNA content as described in Methods.
Cytokine mRNA was quantified using the comparative threshold
method and expressed relative to levels at t=0. Values represent the
median [± IQR] for six experiments using MDM prepared from
separate donor monocytes. No significant differences between cells
exposed to opsonized or unopsonized IE were observed at any time
point (p<0.05, Mann Whitney U test comparing IE with IE-IgG at
each time point).
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TNF in response to IE (median [IQR] = 3.34 [2.04-
4.82] cf 3.60 [1.63-6.51] pg/ml, p=0.30 for unprimed
and median [IQR] = 6.11[3.67] cf 5.30 [2.70-7.01] pg/
ml, p=0.81 for primed MDM, Figure 4D and E respect-
ively). MDM exposed to human erythrocytes secreted
low levels of IL-6 (26.0 [7.52-44.0] pg/ml) with a trend
to increased secretion following incubation with unop-
sonized IE (169 [20.2-246] pg/ml, p = 0.078,
Figure 4G). When IFN-γ-primed MDM were exposed
to unopsonized IE there was a significant increase in
IL-6 secretion compared to the erythrocyte control
(692 [182–996] pg/ml cf 57.9 [46.6-115] pg/ml, p =
0.023, Figure 4H). In separate experiments, the impact
of antibody opsonization of IE on cytokine release from
IFNγ primed MDM was determined. Incubation of
IFN-γ-primed MDM with PPS-opsonized IE resulted in
secretion of IL-1β (median [IQR] = 18.6 [34.2-14.4] cf
3.48 [4.88-1.07] pg/ml p=0.0091 compared to IE,
Figure 4C). Incubation of IFN-γ-primed MDM with
opsonized IE resulted in TNF secretion (median [IQR] =
113 [421–17.0] pg/ml, compared with 14.0 [92.8-1.21]
pg/ml for unopsonized IE, p=0.0091, Figure 4F). The
amount of IL-6 secreted was further increased on expos-
ure to PPS-opsonized IE (2195 [4658–1095] pg/ml cf
622 pg/ml [1250–240], p = 0.0177, Figure 4I). Taken to-
gether these data show that exposure to unopsonized IE
elicited secretion of IL-6 but not TNF or IL-1β, and ex-
posure to IE opsonized with immune serum increased
secretion of all cytokines. These levels compare with a
median of 33.5 [41.6-20.8] pg/ml IL-1β, 9,120 [10,600-
8,130] pg/ml IL-6 and 1,960 [3,230-1,160] pg/ml TNF
produced in response to the positive control 1 ng/ml
LPS (data not shown). As an additional control it was
shown in separate experiments that the levels of TNF,
IL-1β and IL-6 secreted in response to IE opsonised with
non-immune sera were similar to those secreted in re-
sponse to unopsonised IE (TNF: 518.8 [1184–490.0] pg/
ml cf 648.6[1195–487.9] pg/ml; IL-1b: 50.70 [159.0-
39.77] pg/ml cf 58.89 [170.4-43.25] pg/ml; IL-6: 5895
[7525–4899] pg/ml cf 6583[7381–4690] pg/ml, n=3).
Secretion of IL-10 and IL-12 in response to either opso-
nized or unopsonized IE was not observed. In contrast,
robust secretion of IL-8 was observed, but values
exceeded the recommended upper limit of detection of
the cytokine bead array assay, and therefore IL-8 re-
sponse was not further analysed in this study.
Can IL-1β secretion be induced without IE internalization?
Secretion of IL-1β was only observed with opsonized IE.
The potential role of Fcγ receptors in this process was
therefore considered, in particular whether the ability of
these receptors to promote internalization of IE was
required or whether signal transduction following binding
Figure 3 Exposure of MDM to opsonized and unopsonized CS2 IE activates NF-κB to similar extents. MDM (1x106) were primed with
IFN-γ for 48 hr, treated with media alone (MDM), 2x107 unopsonized IE or IE opsonized with pooled immune patient serum (IE-PPS) for 24 hr
followed by preparation of nuclear and cytoplasmic extracts. (A) Extracts were analysed by immunoblotting using antibodies detecting the p50
and p65 NF-κB subunits. Blots were re-probed using antibodies to GAPDH and TATA-binding protein (TBP) to assess the purity of cytoplasmic
(C) and nuclear (N) fractions respectively. (B) IFN-γ-primed MDM were incubated with IE-PPS or IE or incubated in medium alone (MDM) for 24 hr,
and nuclear extracts prepared as in (A). Binding of nuclear proteins to an NF-κB specific oligonucleotide was analysed using EMSA as described
in Methods. Saturable binding was indicated by competition using 100-fold excess of unlabelled probe (lanes 4,6), specificity of binding by lack
of competition using a mutant oligonucleotide probe (lanes 5,7) and the presence of p50 and p65 in DNA binding complexes confirmed by
incubation with anti p50 and p65 or control monoclonal antibodies (lanes 8–10). The positions of complexes containing p50/p65 heterodimer
are labelled NF-κB.
Zhou et al. Malaria Journal 2012, 11:343 Page 7 of 13
http://www.malariajournal.com/content/11/1/343of opsonized IE to Fcγ receptors was sufficient. To address
this question MDM were plated onto tissue culture plates
coated with human IgG to trigger Fcγ receptor signalling.
MDM were then exposed to unopsonized IE at the indi-
cated IE:MDM ratio and cytokine secretion into the cul-
ture medium was quantified. Stimulating Fcγ receptor
signalling increased the amount of IL-1β secreted at all
concentrations of added IE (Figure 5A). In contrast, there
was a decrease in the amount of IL-6 secreted (Figure 5B).
Secretion of TNF by MDM plated onto human IgG was
not significantly increased under these conditions
(Figure 5C). To confirm that IE were not ingested in this
system, phagocytosis was measured in parallel cultures
(Figure 5D). Under the conditions of these experiments,unopsonized IE were not ingested and internalization of
opsonized IE (opsonized either with PPS or with rabbit
anti-erythrocyte antiserum) was inhibited, likely due to a
decrease in available Fcγ receptors due to their binding to
the IgG on the plate surface (Figure 5D). These data indi-
cate that secretion of IL-1β in response to CS2 IE may be
stimulated by Fcγ receptor signalling independently of in-
ternalization of IE.
The effect of Fcγ receptor-mediated phagocytosis and
signalling on IL-1β processing in response to trophozoite
stage CS2-IE
IL-1β secretion requires interleukin 1-converting en-
zyme (ICE or caspase-1) activation by the inflammasome
A B C
D E F
G H I
Figure 4 Differential Secretion of IL-1β, TNF and IL-6 in response to opsonized vs unopsonized CS2 IE. MDM from eight independent
donor monocytes were cultured for seven days without 48 hr priming with 100 ng/ml IFN-γ (panels A, D, G) or with IFN-γ priming (panels B, E,
H). MDM were exposed to human erythrocytes (E), CS2 IE or CS2 IE opsonized with PPS (IE-PPS) for 24 hr after which time the culture medium
was analysed for IL-1β, TNF and IL-6 concentration as described in Methods. IFNγ-primed MDM from nine additional donors were exposed to CS2
IE or CS2 IE opsonized with PPS (IE-PPS) (panels C, F, I) for 24 hr and analysed as above. IL-6 concentrations are plotted on a log scale, whereas
TNF and IL-1β are presented on linear scale. Differences were assessed for significance using Wilcoxon matched-pairs signed rank test.
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http://www.malariajournal.com/content/11/1/343[42]. Since IL-1β was secreted in response to opsonized
but not unopsonized CS2 IE, the question of whether
Fcγ receptor phagocytosis and signalling was required
for inflammasome activation was addressed. In three in-
dependent experiments using monocytes derived from
different donors, the effect of caspase inhibition on cyto-
kine secretion in response to both opsonized and unop-
sonized CS2 IE was measured. In agreement withobservations reported above, no IL-1β secretion was
observed in response to unopsonized IE, although IL-6
secretion was. Opsonization induced IL-1β secretion and
stimulated IL-6 secretion. IL-1β secretion in response to
opsonized CS2 IE was inhibited 78% in the presence of
10 mM z-VAD-FMK (Figure 6A) consistent with IL-1β
secretion by macrophages being dependent of the
inflammasome. As expected, IL-6 secretion was not
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Figure 5 Fcγ receptor activation by IgG enhances IL-1β but not IL-6 secretion in the absence of IE ingestion. MDM were grown in Teflon
jars for five days, primed for 48 hr with 100 ng/ml IFN-γ and then seeded in triplicate onto wells of 96-well tissue culture plates coated with
human IgG (●) or left uncoated (○). After MDM had adhered, they were incubated with unopsonized CS2 IE at an IE:MDM ratio of 20:1. After 24
hr culture medium was collected and analysed for secretion of (A) IL-1β (B) TNF and (C) IL-6. Data represent mean ± SEM of six separate
experiments using MDM prepared from independent donor monocytes. Differences at each time point were tested for significance using
Wilcoxon matched pairs test; * p<0.05. (D) In selected experiments MDM were also seeded in triplicate onto IgG-coated (grey bars) or uncoated
(white bars) wells of a separate plate, and phagocytosis of human erythrocytes (E), unopsonized CS2 IE, CS2 IE opsonized with pooled immune
patient serum (IE-PPS) and human erythrocytes opsonized with rabbit anti-human erythrocyte antibody (E-IgG) was measured. Data represent
mean ±SEM of triplicate measurements from a single representative experiment.
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http://www.malariajournal.com/content/11/1/343inhibited by the caspase inhibitor (Figure 6A). MDM
were then exposed to opsonized or unopsonized CS2 IE,
and cell extracts analysed for activation of caspase-1 by
immunoblotting and by enzymatic assay. Exposure to
opsonized IE but not unopsonized IE resulted in cleav-
age of a small proportion of active caspase-1 as evi-
denced by the accumulation of a 10 kDa cleavage
product (Figure 6B). Consistent with this, incubation
with opsonized, but not unopsonized, IE caused an in-
crease in caspase-1 proteolytic activity which was max-
imal 2 hr after exposure to IE (Figure 6C). Thus
engagement of Fcγ receptors by immune serum opso-
nized IE activates components of the inflammasome
associated with IL-1β secretion.
Discussion
The mechanisms of phagocytosis of P. falciparum IE are
well understood, however the pathways regulating the
subsequent inflammatory response, important for control
of parasitaemia, are not. Here it is shown that unopso-
nized CS2 IE, although not internalized by human MDM,
stimulate pro-inflammatory cytokine mRNA expression.
This is associated with a low level of IL-6 secretion but noIL-1β or TNF secretion. Opsonization by immune serum
increases IE internalization via Fcγ receptors without in-
creasing cytokine mRNA levels, and activates components
of the inflammasome leading to IL-1β secretion. These
data are consistent with recently published studies [35] in
which it is shown that HIV infection of MDM inhibits
both internalization and cytokine secretion in response to
IE-PPS. Internalization of IE is not an absolute require-
ment for IL-1β secretion since activation of Fcγ receptors
via plate-bound IgG also causes IL-1β secretion in re-
sponse to uningested, unopsonized IE. Thus Fc-receptor
stimulation coupled with pattern recognition receptor en-
gagement by IE ligands is sufficient to initiate IL-1β se-
cretion. In contrast, opsonization of IE stimulates IL-6
secretion, likely via a mechanism dependent on ingestion
since plate-bound IgG inhibits both ingestion of, and IL-6
secretion in response to, unopsonized IE.
The present study investigated cytokine responses to
purified CS2 trophozoite-infected erythrocytes. CS2 is a
laboratory-derived P. falciparum strain, obtained by selec-
tion for CSA binding [36] similar to pregnancy-associated
malaria strains. It does not bind the class B scavenger re-
ceptor CD36, and consequently CS2-infected erythrocytes
Figure 6 IL-1β secretion is partially dependent on caspase activity, which is stimulated by IgG opsonization. (A) MDM, cultured in
96-well plates, were primed with 100 ng/ml IFN-γ for 48 hr then pre-incubated as indicated with the pan-caspase inhibitor z-VAD-fmk (10 μM),
for 2 hr then exposed to CS2 IE opsonized with rabbit anti-human erythrocyte antibody. Supernatants from replicate wells were pooled and
analysed using cytokine bead array. Results represent mean ± SEM from three independent experiments using monocytes from different donors.
(B) 3 x 106 IFN-γ-primed MDM, cultured in 6 cm dishes, were incubated for 4 hr with 6x107 CS2 IE either unopsonized or opsonized with rabbit
anti-human erythrocyte antibody as indicated. Cells were lyzed in RIPA buffer and analysed by immunoblotting using an antibody that recognizes
caspase-1 and the 10 kDa cleaved activated subunit of caspase-1. Mono: positive control lysate prepared from autologous purified human
monocytes, which show high levels of cleaved caspase-1. MDM incubated in the absence of added trophozoites (−), with unopsonized
trophozoites (IE) and with IgG opsonized trophozoites (IE-IgG). Gels were re-probed with anti-GAPDH (lower panel) as a loading control. Results
are representative of three experiments using separate donor monocytes. (C) MDM cultured and incubated with CS2 IE for the indicated times
as in (B) were lyzed with a commercial lysis buffer and analysed for caspase-1 activity using a fluorometric assay kit as described in Methods.
Data show mean ± SEM fold increase in caspase-1 activity in one experiment, representative of three using separate donor monocytes, each
performed in triplicate.
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state. By using this strain, it was possible to dissect the re-
quirement for internalization for some macrophage cyto-
kine responses. The observation that unopsonized IE
stimulate NF-κB activation, mRNA expression and some
IL-6 secretion was surprising and suggests that surface
pattern recognition receptors activate signalling pathways
sufficiently to allow for cytokine gene transcription via ac-
tivation of the NF-kB pathway but that additional signal-
ling pathways must be activated in order to support
robust cytokine synthesis and secretion. These additional
signalling pathways may be activated following binding to
opsonic receptors on the cell surface or to endosomal pat-
tern recognition receptors following phagocytosis.
These observations may suggest that surface pattern
recognition receptors, in addition to endosomal receptors,
play a role in cytokine elicitation in response to IE. It has
been shown that toll-like receptor 2 (TLR2) stimulatespro-inflammatory cytokine production in response to
parasite-derived glycosylphosphatidylinositol [43] and
TLR4 stimulates TNF secretion in response to peroxire-
doxin [44]. TLR9 has been reported to recognize haemo-
zoin [45], possibly complexed with DNA and lipid [46,47].
In contrast, Wu et al. demonstrated that cytokine produc-
tion by murine bone marrow-derived dendritic cells, in re-
sponse to schizont bursts, were mainly due to recognition
by a TLR9-dependent mechanism of protein DNA com-
plexes released from merozoites [48,49] and that haemo-
zoin is inert in this response. Using a mouse model of
malaria infection, the same authors showed that the TLR9
response is particularly important in early infection to
produce dendritic cell-derived pro-inflammatory cytokines
although other mechanisms are required for IL-1β secre-
tion [50]. In the above-mentioned studies, endosomal
toll–like receptors were presumed to become activated
following delivery of parasite ligands into phagolysosomes.
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activation of pattern recognition receptors and NF-κB sig-
nalling occurs in the absence of ingestion. The ligand(s)
present on the IE surface which stimulate this response,
and the relevant pattern-recognition receptors, remain to
be identified. The purified parasite preparations used were
essentially without free haemozoin and schizont stages, as
determined by microscopy, which is consistent with the
observations of poor cytokine responses and low caspase-
1 activation with unopsonized IE, since soluble haemozoin
stimulates IL-1β release via activation of the NALP3
inflammasome [47]. The lack of IL-1β or TNF secretion in
response to unopsonized IE also shows that the experi-
ments on cytokine secretion in response to IE were not
confounded by lysis of IE and release of haemozoin from
IE during the incubation as this would have induced
inflammasome activation and IL-1β secretion [51].
Additional signalling required for robust pro-
inflammatory responses may be downstream of Fcγ
receptors and/or be activated by internal pattern recog-
nition receptors recognizing ligands in the IE that are
released following ingestion of the cells. Whether there
is a qualitative difference in the cytokines produced in
response to these different pathways remains to be
determined. Recent studies have suggested that murine
dendritic cells require the presence of multiple Toll-like
receptors to induce TNF secretion in response to schiz-
ont stage murine malaria parasites since NF-κB nuclear
translocation, TNF secretion and dendritic cell activation
are abrogated in bone marrow-derived dendritic cells
obtained from TLR9, TLR4 and MyD88 knockout mice
[52]. These data suggest that schizont ligands require
concerted action of several receptors to generate a
robust cytokine response, similar to the data presented
here, but the role of internalization and of opsonic
receptors was not studied.
Data reported herein, using the CS2 parasite strain,
differ from those reported using CD36-binding isolates
[53]. In the study by Erdman and co-workers, CD36 sig-
nalling was shown to inhibit pro-inflammatory cytokine
production by macrophages exposed to unopsonized IE.
Whether CD36 will also block Fc receptor-induced cyto-
kine production remains to be established. The observa-
tion that this does not occur with the CSA-binding
strain CS2, has implications for cytokine production in
maternal malaria, which involves accumulation of CSA-
binding parasites in the placenta. Production of pro-
inflammatory cytokines is an important component of
the early response against malaria infection but may also
contribute to immunopathology. In particular the pro-
duction of endogenous pyrogens such as TNF, IL-1β and
IL-6 following IFN-γ stimulation of monocytes/macro-
phages may be responsible for fever induction [54] and
sustained IL-1β production may be associated withanaemia [55]. The potential roles of pro-inflammatory
cytokines in pathology in the setting of maternal malaria
are reviewed elsewhere [1]. The ability of opsonized IE
to stimulate pro-inflammatory cytokine production by
MDM following phagocytosis and its relationship to pro-
tection from malaria need to be addressed.
Conclusions
The data presented in this paper show that generating
antibody responses to blood-stage malaria parasites is
potentially beneficial both in reducing parasitaemia via
Fcγ receptor-dependent macrophage phagocytosis and in
generating a robust pro-inflammatory response.
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